# The Differential Effects of Diabetes Therapy on Inflammation

> **NCT02150707** · — · COMPLETED · sponsor: **University College Dublin** · enrollment: 17 (actual)

## Conditions studied

- Diabetic Nephropathy
- Type 2 Diabetes

## Interventions

- **DRUG:** Dipeptidyl-Peptidase IV Inhibitors
- **DRUG:** Glucagon-Like Peptide 1

## Key facts

- **NCT ID:** NCT02150707
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02150707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02150707, "The Differential Effects of Diabetes Therapy on Inflammation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02150707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*